S

Sergey M. Deyev

Institute of Bioorganic Chemistry

ORCID: 0000-0002-3952-0631

Publishes on Monoclonal and Polyclonal Antibodies Research, Nanoplatforms for cancer theranostics, HER2/EGFR in Cancer Research. 383 papers and 7.6k citations.

PubIndex Score75Top 25% · seniorHow it's scored

383Publications

7.6kTotal Citations

First publication: 1973First senior author: 1996

Monoclonal and Polyclonal Antibodies Research Nanoplatforms for cancer theranostics HER2/EGFR in Cancer Research Radiopharmaceutical Chemistry and Applications Nanoparticle-Based Drug Delivery

Top publicationsby citations

Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth

Ivan V. Zelepukin, Maxim P. Nikitin, Alexey V. Yaremenko et al.|Nanoscale|2018

Cited by 180

Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery

Ivan V. Zelepukin, Sergey M. Deyev, Konstantin G. Shevchenko|Nature Communications|2024

Cited by 162

Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes

Maxim P. Nikitin, Petr I. Nikitin, Sergey M. Deyev et al.|Nature Biomedical Engineering|2020

Cited by 146

Fast processes of nanoparticle blood clearance: Comprehensive study

Ivan V. Zelepukin, Maxim P. Nikitin, Petr I. Nikitin et al.|Journal of Controlled Release|2020

Cited by 93

Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors

Iaroslav B. Belyaev, Ivan V. Zelepukin, Olga Yu. Griaznova et al.|Advanced Drug Delivery Reviews|2025

Cited by 89